<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="iso-abbrev">An Bras Dermatol</journal-id>
      <journal-title-group>
        <journal-title>Anais Brasileiros de Dermatologia</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0365-0596</issn>
      <issn pub-type="epub">1806-4841</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Dermatologia</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">26375229</article-id>
      <article-id pub-id-type="pmc">4560549</article-id>
      <article-id pub-id-type="doi">10.1590/abd1806-4841.20153247</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Sweet Syndrome in childhood<xref ref-type="fn" rid="fn01">*</xref></article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>dos Santos</surname>
            <given-names>Talita Batalha Pires</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
          <xref ref-type="corresp" rid="c01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sales</surname>
            <given-names>Barbara Cristina Gouveia</given-names>
          </name>
          <xref ref-type="aff" rid="aff02">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sigres</surname>
            <given-names>Marianne</given-names>
          </name>
          <xref ref-type="aff" rid="aff02">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Rosman</surname>
            <given-names>Fernando</given-names>
          </name>
          <xref ref-type="aff" rid="aff02">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>de Cerqueira</surname>
            <given-names>Ana Maria Mosca</given-names>
          </name>
          <xref ref-type="aff" rid="aff02">2</xref>
        </contrib>
      </contrib-group>
      <aff id="aff01"><label>1</label>Universidade Federal Fluminense (UFF) - Niter&#xF3;i (RJ),
Brazil</aff>
      <aff id="aff02"><label>2</label>Hospital Municipal Jesus - Rio de Janeiro (RJ),
Brazil.</aff>
      <author-notes>
        <corresp id="c01">MAILING ADDRESS: Talita Batalha Pires dos Santos, Rua Oito de
dezembro, 717, Vila Isabel, 20550-200 Rio de Janeiro-RJ. E-mail:
<email>dra.talitabatalha@hotmail.com</email></corresp>
      </author-notes>
      <pub-date pub-type="epub-ppub">
        <season>Jul-Aug</season>
        <year>2015</year>
      </pub-date>
      <!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' -->
      <pub-date pub-type="ppub">
        <season>Jul-Aug</season>
        <year>2015</year>
      </pub-date>
      <volume>90</volume>
      <issue>4</issue>
      <fpage>567</fpage>
      <lpage>569</lpage>
      <history>
        <date date-type="received">
          <day>04</day>
          <month>11</month>
          <year>2013</year>
        </date>
        <date date-type="accepted">
          <day>19</day>
          <month>12</month>
          <year>2013</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2015 by Anais Brasileiros de Dermatologia</copyright-statement>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">
          <license-p>This is an Open Access article distributed under the terms of the Creative
Commons Attribution Non-Commercial License which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the
original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Sweet syndrome or acute febrile neutrophilic dermatosis is a recurrent and rare skin
disease caused by the release of cytokines, with diverse possible etiologic causes.
It presents clinically with polymorphic skin lesions, fever, arthralgia, and
peripheral leukocytosis. In general, it is associated with infections, malignancy and
drugs. It usually regresses spontaneously and treatment is primarily to control the
basic disease. The authors report the case of a child of 1 year and 11 months who
developed Sweet syndrome.</p>
      </abstract>
      <kwd-group>
        <kwd>Case reports</kwd>
        <kwd>Child</kwd>
        <kwd>Sweet Syndrome</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>INTRODUCTION</title>
      <p>Sweet Syndrome is a febrile neutrophilic dermatosis, characterized by the onset of
painful erythematous-violaceous lesions that may be located mainly on limbs, trunk, face
and neck.<sup><xref rid="r01" ref-type="bibr">1</xref>,<xref rid="r02" ref-type="bibr">2</xref></sup></p>
      <p>The disease is universally distributed among the races. In adults, women are more
commonly affected, mainly with the idiopathic and drug-induced forms. The first episode
generally occurs between the ages of 30 and 50 years.<sup><xref rid="r01" ref-type="bibr">1</xref>,<xref rid="r03" ref-type="bibr">3</xref></sup> The cases
associated with neoplasms, on the other hand, are equally distributed between the
genders.<sup><xref rid="r03" ref-type="bibr">3</xref></sup> The cases described in
children are rare (8% of the total), equally distributed between the genders and are
preceded by three to one week by infectious diseases of the upper respiratory
tract.<sup><xref rid="r01" ref-type="bibr">1</xref>,<xref rid="r03" ref-type="bibr">3</xref></sup></p>
      <p>Remission of cutaneous symptoms is variable; without treatment the lesions may persist
for several months or even experience spontaneous remission. In case of relapse, there
is strong association with malignant diseases such as neoplasm recurrence.<sup><xref rid="r01" ref-type="bibr">1</xref>,<xref rid="r03" ref-type="bibr">3</xref></sup></p>
    </sec>
    <sec>
      <title>CASE REPORT</title>
      <p>Patient, female, one year and eleven months old, with onset of erythematous-papular
lesions on the forehead for around 3 weeks that progressed to erythematous-violaceous
lesions in plaques involving all the face (<xref ref-type="fig" rid="f01">Figures
1</xref> and <xref ref-type="fig" rid="f02">2</xref>). There was also onset of
lesions on the lower limbs bilaterally, mainly on the posterior surface of limbs,
characterized by erythematous plaques with raised borders and central necrosis (<xref ref-type="fig" rid="f03">Figure 3</xref>). There was no itching and discreet pain in
lower limb lesions. She did not present lesions in the oral cavity, trunk, palms and
soles of feet. She had been using ferrous sulfate and montelukast sodium for 3
months.</p>
      <fig id="f01" orientation="portrait" position="float">
        <label>FIGURE 1</label>
        <caption>
          <p>Erythematous-violaceous plaques on right hemiface</p>
        </caption>
        <graphic xlink:href="abd-90-04-0567-g01"/>
      </fig>
      <fig id="f02" orientation="portrait" position="float">
        <label>FIGURE 2</label>
        <caption>
          <p>Erythematous-violaceous plaques on left hemiface</p>
        </caption>
        <graphic xlink:href="abd-90-04-0567-g02"/>
      </fig>
      <fig id="f03" orientation="portrait" position="float">
        <label>FIGURE 3</label>
        <caption>
          <p>Erythematous plaques on posterior surface of lower limbs with elevated borders and
central ulceration (target aspect)</p>
        </caption>
        <graphic xlink:href="abd-90-04-0567-g03"/>
      </fig>
      <p>During the last week the patient had fever varying between 37.5&#xBA;C and 38.5&#xBA;C. She was
eating well, without vomit and/or diarrhea. The following tests were requested:</p>
      <list list-type="bullet">
        <list-item>
          <p>Hemogram: red blood cells 4,000,000; hemoglobin 9.91; hematocrit 31; platelets
442,000</p>
        </list-item>
        <list-item>
          <p>Leukogram: 12,300 leukocytes with 51% segmented, 2% band neutrophils, 34%
lymphocytes and 8% eosinophils</p>
        </list-item>
        <list-item>
          <p>EAS: volume 20ml, density 1010, slightly cloudy, citrine in color, 20-30 pyocytes,
5-8 red blood cells, ketone bodies (1+).</p>
        </list-item>
        <list-item>
          <p>Biochemical tests, abdomen ultrasound and thorax X-ray without alterations.</p>
        </list-item>
      </list>
      <p>A cutaneous incisional biopsy was done on a lesion on a left lower limb. Treatment for
urinary infection was started with cephalexin (100mg/kg/day) and prednisolone
(1mg/kg/day) for one week. The histopathologic result was febrile neutrophilic
dermatosis (<xref ref-type="fig" rid="f04">Figures 4</xref> and <xref ref-type="fig" rid="f05">5</xref>). After 5 weeks of treatment with oral corticotherapy there was
clear improvement of lesions, mainly edema regression, infiltration and erythema, in
addition to absence of febrile symptoms.</p>
      <fig id="f04" orientation="portrait" position="float">
        <label>FIGURE 4</label>
        <caption>
          <p>100x - Perivascular neutrophilic nodular infi ltrates. Important edema of the
papillary dermis</p>
        </caption>
        <graphic xlink:href="abd-90-04-0567-g04"/>
      </fig>
      <fig id="f05" orientation="portrait" position="float">
        <label>FIGURE 5</label>
        <caption>
          <p>400x- Perivascular neutrophilic nodular infi ltrates in middle and upper
dermis</p>
        </caption>
        <graphic xlink:href="abd-90-04-0567-g05"/>
      </fig>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>The Sweet Syndrome (SS) is an acute, febrile neutrophilic dermatosis, first described by
Robert Douglas Sweet, in 1964<sup><xref rid="r01" ref-type="bibr">1</xref></sup><sub>.</sub> It is characterized by the acute onset of fever,
erythematous-violaceous cutaneous lesions, usually painful, located mainly on limbs,
trunk, face or neck.<sup><xref rid="r02" ref-type="bibr">2</xref></sup> The inflammatory
edema may impart the aspect of lesions with vesiculations, but palpation shows that
actually the lesions are solid, somewhat softened; the name given to this is
pseudovesiculation. As the lesion regresses, there may be a central lightening of the
lesion color, giving it a target aspect similar to erythema multiforme.<sup><xref rid="r01" ref-type="bibr">1</xref>,<xref rid="r02" ref-type="bibr">2</xref></sup></p>
      <p>Women are more frequently affected and seem to be particularly involved by the
idiopathic or drug-induced forms.<sup><xref rid="r01" ref-type="bibr">1</xref>,<xref rid="r04" ref-type="bibr">4</xref></sup> The onset is habitually described as
occurring between the ages of 30 and 60 years, being rare in childhood.<sup><xref rid="r02" ref-type="bibr">2</xref>,<xref rid="r04" ref-type="bibr">4</xref></sup></p>
      <p>It is frequently related to infectious diseases, inflammatory diseases, drugs and
neoplasms.<sup><xref rid="r02" ref-type="bibr">2</xref></sup> Neoplasms are
associated with malignant disease at a rate of 21%, usually as hematologic
disorder.<sup><xref rid="r01" ref-type="bibr">1</xref>,<xref rid="r02" ref-type="bibr">2</xref></sup>The neoplasm more commonly linked to SS is Acute Myeloid
Leukemia (AML).<sup><xref rid="r01" ref-type="bibr">1</xref>,<xref rid="r02" ref-type="bibr">2</xref>,<xref rid="r04" ref-type="bibr">4</xref></sup></p>
      <p>In pediatric patients, the dermatosis is usually preceded by signs and symptoms of
infection in the upper respiratory tract, from one to three weeks before the onset of
cutaneous lesions.<sup><xref rid="r04" ref-type="bibr">4</xref>,<xref rid="r05" ref-type="bibr">5</xref></sup> Vacaro et al<sup><xref rid="r04" ref-type="bibr">4</xref></sup> suggested that infectious agents might be triggers of reactive skin
diseases, either through direct damage or molecular mimicry.<sup><xref rid="r06" ref-type="bibr">6</xref></sup></p>
      <p>The pathogenesis of the disease suggests vasculitis by altered immune complex and
neutrophil function. The authors presume that the child developed the classical or
idiopathic form of the disease. Montelukast sodium acts as inhibitor of
leukotrienes.<sup><xref rid="r07" ref-type="bibr">7</xref></sup> Leukotrienes
stimulate leukocyte function, including lysosomal enzyme release, polymorphonuclear
leukocyte adhesion and aggregation. Therefore, their inhibition would go against the SS
theory. As the child presented the reaction for the first time and all tests were within
normal standards, the authors also believed, at first, that a relationship with
neoplasms was not very likely.</p>
      <p>The diagnostic criteria for SS were proposed by Su and Liu in 1986 and modified by Von
den Driesch in 1994.<sup><xref rid="r06" ref-type="bibr">6</xref></sup> In order to
receive this diagnosis the patient must have 2 major criteria and 2 minor criteria. We
can cite as major criteria: 1) the sudden onset of painful erythematous or violaceous
plaques or nodules; 2) a predominantly neutrophilic dermal infiltrate, without
leukocytoclastic vasculitis. The minor ones would be: 1) fever or prior infection; 2)
arthralgia, conjunctivitis or malignancy; 3) leukocytosis; 4) favorable response to use
of corticosteroid therapy.</p>
      <p>Histopathology shows visible perivascular neutrophilic nodular infiltrates, with
necrophiliac cariorrexis. Even though there is no primary vasculitis, blood vessels may
be secondarily involved in immunologic response, an infrequent finding.<sup><xref rid="r06" ref-type="bibr">6</xref>,<xref rid="r08" ref-type="bibr">8</xref></sup></p>
      <p>Laboratory alterations include peripheral leukocytosis with neutrophilia and elevated
speed of erythrocyte sedimentation or C-reactive protein, particularly in cases where SS
associated with malignancy, leukopenia, anemia and thrombocytopenia have been
reported.<sup><xref rid="r03" ref-type="bibr">3</xref>,<xref rid="r09" ref-type="bibr">9</xref>,<xref rid="r10" ref-type="bibr">10</xref></sup></p>
      <p>We may cite as differential diagnoses erythema multiforme, erythema nodosum, erythema
elevatum diutinum, Hansen's disease, pyoderma gangrenosum, bromoderma, leukocytoclastic
vasculitis and facial granuloma with eosinophilia.<sup><xref rid="r08" ref-type="bibr">8</xref></sup></p>
      <p>The treatment is based on corticosteroid therapy, either oral (30 to 60mg/day for 4 to 6
weeks) or intralesional<sup><xref rid="r01" ref-type="bibr">1</xref>-<xref rid="r06" ref-type="bibr">6</xref></sup>. In the studied case oral corticosteroid
therapy was chosen due to dissemination of lesions and because that was the recommended
way for the patient's age group.</p>
      <p>The lesions usually leave no scars and even without treatment tend to achieve
spontaneous cure in 2 to 4 weeks. There frequently are recurrences in between 30 and 50%
of cases<sup><xref rid="r06" ref-type="bibr">6</xref>-<xref rid="r10" ref-type="bibr">10</xref></sup>, depending on the etiology.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="conflict">
        <p>Conflict of Interest: None.</p>
      </fn>
      <fn fn-type="supported-by">
        <p>Financial Support: None.</p>
      </fn>
      <fn fn-type="other">
        <p><bold>How to cite this article:</bold> Santos TBP, Sales BCG, Sigres M, Rosman F,
Cerqueira AMM. Sweet Syndrome in childhood. AnBrasDermatol. 2015;90(4):567-9.</p>
      </fn>
      <fn fn-type="other" id="fn01">
        <label>*</label>
        <p>Study carried out at the Hospital Municipal Jesus- Rio de Janeiro (RJ), Brazil.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="r01">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wojcik</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Nishimori</surname>
              <given-names>FS</given-names>
            </name>
            <name>
              <surname>Santamar&#xED;a</surname>
              <given-names>JR</given-names>
            </name>
          </person-group>
          <article-title>Sweet's syndrome: a study of 23 cases</article-title>
          <source>An Bras Dermatol</source>
          <year>2011</year>
          <volume>86</volume>
          <fpage>265</fpage>
          <lpage>271</lpage>
          <pub-id pub-id-type="pmid">21603809</pub-id>
        </element-citation>
      </ref>
      <ref id="r02">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Leilao</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Reis</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Malcata</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Sindrome de Sweet. Afec&#xE7;&#xE3;o benigna ou sist&#xEA;mica grave</article-title>
          <source>Medicina Interna</source>
          <year>1996</year>
          <volume>3</volume>
          <fpage>24</fpage>
          <lpage>28</lpage>
        </element-citation>
      </ref>
      <ref id="r03">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bonamigo</surname>
              <given-names>RR</given-names>
            </name>
            <name>
              <surname>Razera</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Olm</surname>
              <given-names>GS</given-names>
            </name>
          </person-group>
          <article-title>Neutrophilic dermatoses: part I</article-title>
          <source>An Bras Dermatol</source>
          <year>2011</year>
          <volume>86</volume>
          <fpage>11</fpage>
          <lpage>25</lpage>
          <pub-id pub-id-type="pmid">21437518</pub-id>
        </element-citation>
      </ref>
      <ref id="r04">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ribeiro</surname>
              <given-names>LH</given-names>
            </name>
            <name>
              <surname>Sampaio</surname>
              <given-names>RF</given-names>
            </name>
          </person-group>
          <article-title>Breve revisao Sindrome de Sweet</article-title>
          <source>RBM</source>
          <year>2010</year>
          <volume>67</volume>
        </element-citation>
      </ref>
      <ref id="r05">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ramos</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Santiago</surname>
              <given-names>LM</given-names>
            </name>
            <name>
              <surname>Tome</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Um caso tipico de Sindrome de Sweet</article-title>
          <source>Rev Port Med Geral Fam</source>
          <year>2013</year>
          <volume>29</volume>
          <fpage>186</fpage>
          <lpage>190</lpage>
        </element-citation>
      </ref>
      <ref id="r06">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Walker</surname>
              <given-names>DC</given-names>
            </name>
            <name>
              <surname>Cohen</surname>
              <given-names>PR</given-names>
            </name>
          </person-group>
          <article-title>Trimethoprim-sulfamethoxazole-associated acute febrile dermatosis:
case report and review of drug-induced Sweet's syndrome</article-title>
          <source>J Am Acad Dermatol</source>
          <year>1996</year>
          <volume>34</volume>
          <fpage>918</fpage>
          <lpage>923</lpage>
          <pub-id pub-id-type="pmid">8621829</pub-id>
        </element-citation>
      </ref>
      <ref id="r07">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wandalsen</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Coppini</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Castro</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Montelucaste como monoterapia para asma e rinite
persistente</article-title>
          <source>Rev Bras Alerg Imunopatol</source>
          <year>2006</year>
          <volume>29</volume>
          <fpage>94</fpage>
          <lpage>99</lpage>
        </element-citation>
      </ref>
      <ref id="r08">
        <label>8</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Wolff</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Johnson</surname>
              <given-names>RA</given-names>
            </name>
          </person-group>
          <source>Dermatologia de Fitzpatrick</source>
          <edition>6. ed</edition>
          <publisher-loc>Porto Alegre</publisher-loc>
          <publisher-name>AMGH</publisher-name>
          <year>2011</year>
        </element-citation>
      </ref>
      <ref id="r09">
        <label>9</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Sampaio</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Rivitti</surname>
              <given-names>EA</given-names>
            </name>
          </person-group>
          <source>Dermatologia</source>
          <edition>3. ed</edition>
          <publisher-loc>S&#xE3;o Paulo</publisher-loc>
          <publisher-name>Artes Medicas</publisher-name>
          <year>2007</year>
        </element-citation>
      </ref>
      <ref id="r10">
        <label>10</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Bolognia</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Jorizzo</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Rapini</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <source>Dermatology.</source>
          <publisher-loc>St. Louis, MO</publisher-loc>
          <publisher-name>Mosby Elsevier</publisher-name>
          <year>2008</year>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
